Archive for March 2021
With CFO’s exit, upheaval continues at Berkshire Bank
Berkshire Chief Financial Officer Jamie Moses is leaving the Boston-based lender for another company. He has played a key role in the recent drama between Berkshire and one of its shareholders, HoldCo Asset Management LP. Read More
Read MoreRaytheon CEO Greg Hayes’s compensation dipped in 2020
Hayes’s total pay was over 190 times higher than that of the median global employee of the defense contractor (NYSE: RTX). Read More
Read MoreNew York architecture firm expands into Boston, Atlanta
A New York architecture and interior design firm is expanding into Boston and Atlanta. Read More
Read MoreTranslate Bio’s Covid-19 vaccine candidate enters clinical trials
Another Massachusetts-born mRNA vaccine is making its way into the clinic as the need for Covid-19 vaccines grows more pressing. Read More
Read MoreFlywire says it plans IPO, but files confidentially with SEC
The payments technology company was one of a handful of tech company in Boston rumored to go public in 2021. Data market research firm PitchBook included AI company DataRobot Inc. and cybersecurity provider Cybereason Inc. in its IPO pipeline predictions. Boston-based Toast Inc. is also reportedly eyeing an IPO that could value the restaurant software…
Read MoreNominations are open for Rhode Island Inno’s Fire Awards
Drumroll, please: Nominations for Rhode Island Inno’s annual Fire Awards are now open. Submit your picks here by April 2. Read More
Read MoreGE CEO Larry Culp’s pay package was 1,350 times bigger than typical worker’s
Nearly all of the GE chief executive’s compensation came in the form of stock awards that will not vest until later years. Read More
Read MoreThis Salem biotech uses live human skin to test drugs and cosmetics
Inside a nondescript building off Technology Way in Salem, a French biotech company is quietly developing technology that it believes could change the way preclinical testing works globally. Rather than animal models or organ chips, GenoSkin is packaging and selling a different kind of testing material: live human skin. Read More
Read MoreForm D Friday: Cambridge gene editing company raises this week’s largest round
Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. Read More
Read MoreFive things you need to know today, and the question on everyone’s mind
Good morning, Boston. Here are the 5 Things You Need to Know today, plus the latest local SPAC, the newest local billionaire, things to do, and the question on everyone’s mind. Read More
Read More